SMS Lifesciences India Ltd receives EIR from USFDA for API manufacturing facility

article continues after this advertisement

SMS Lifesciences India Ltd’s API manufacturing facility located at Sy. No. 180/2. Kazipally. Jinnaram Mandal, Sangareddy district. Telangana. has received Establishment Inspection Report (EIR) from U.S. Food and Drug Administration (US FDA) for the inspection conducted in the month of April, 2022.

The EIR from US FDA Indicates successful completion ot the Inspection without any observations.